Diagnostic et traitement des complications neurologiques des immunothérapies anticancéreuses
A Farina, B Joubert - Pratique Neurologique-FMC, 2023 - Elsevier
Résumé Les immunothérapies anticancéreuses sont des traitements de développement
récent qui stimulent l'immunité antitumorale des patients atteints de cancer, soit au moyen …
récent qui stimulent l'immunité antitumorale des patients atteints de cancer, soit au moyen …
Complications neurologiques des immunothérapies anti-cancéreuses: une pathologie émergente
B Joubert - Pratique Neurologique-FMC, 2020 - Elsevier
Résumé Les immunothérapies anti-cancéreuses sont un ensemble de traitements de
développement récent qui visent à stimuler l'immunité anti-tumorale, soit au moyen …
développement récent qui visent à stimuler l'immunité anti-tumorale, soit au moyen …
Neurological Complications of Immune-Based Therapies
UN Chukwueke, EQ Lee, PY Wen - Central Nervous System Metastases, 2020 - Springer
As collective knowledge of the immunological underpinnings of disease has risen, this has
spurred the development and use of new, immune-based cancer therapies. While …
spurred the development and use of new, immune-based cancer therapies. While …
[HTML][HTML] Neurological complications of cancer immunotherapy
P Roth, S Winklhofer, AMS Müller, R Dummer… - Cancer Treatment …, 2021 - Elsevier
Immunotherapy has emerged as a powerful therapeutic approach in many areas of clinical
oncology and hematology. The approval of ipilimumab, a monoclonal antibody targeting the …
oncology and hematology. The approval of ipilimumab, a monoclonal antibody targeting the …
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy
C Perrinjaquet, N Desbaillets… - Current opinion in …, 2019 - journals.lww.com
Neurotoxicity associated with cancer immunotherapy: immune c... : Current Opinion in Neurology
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric …
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric …
Neurology of cancer immunotherapy
A De Grado, F Cencini, A Priori - Neurological Sciences, 2023 - Springer
Background Immunotherapy is nowadays considered a mainstay of cancer treatment,
dramatically affecting the disease-free survival rate in several aggressive malignancies …
dramatically affecting the disease-free survival rate in several aggressive malignancies …
Neurologic complications of cancer immunotherapy
N Wang - CONTINUUM: Lifelong Learning in Neurology, 2023 - journals.lww.com
Objective Immunotherapeutic approaches have revolutionized cancer treatment with
immune checkpoint inhibitors and adoptive T-cell therapy now approved to treat a variety of …
immune checkpoint inhibitors and adoptive T-cell therapy now approved to treat a variety of …
Neurotoxicity of novel cancer immunotherapies
MD Willis, NP Robertson - Journal of Neurology, 2019 - Springer
Novel immunotherapies are emerging as an exciting treatment for a variety of
haematological and solid malignancies. Chimeric antigen receptor (CAR) T cells and …
haematological and solid malignancies. Chimeric antigen receptor (CAR) T cells and …
Central nervous system injury from novel cancer immunotherapies
SF Winter, EJ Vaios, J Dietrich - Current Opinion in Neurology, 2020 - journals.lww.com
Central nervous system injury from novel cancer immunotherap... : Current Opinion in Neurology
Central nervous system injury from novel cancer immunotherapies : Current Opinion in …
Central nervous system injury from novel cancer immunotherapies : Current Opinion in …
Actualités dans le diagnostic et le traitement des encéphalites auto-immunes
F Lamblin, B Joubert, J Honnorat - Pratique Neurologique-FMC, 2023 - Elsevier
Résumé Les encéphalites auto-immunes (EAI) sont des pathologies rares et potentiellement
graves représentant un champ émergeant et dynamique de la neuro-immunologie. Elles …
graves représentant un champ émergeant et dynamique de la neuro-immunologie. Elles …